These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 417340)

  • 1. [Obtaining the homologous hyperimmune preparations from the blood of immunized donors - anti-coli (anti-Escherichia) and antitoxic antipyocyanotic plasma].
    Skurkovich SV; Likhoded VG; Krokhina MA; Temper RM; Demidova NV
    Probl Gematol Pereliv Krovi; 1978 Feb; 23(2):51-3. PubMed ID: 417340
    [No Abstract]   [Full Text] [Related]  

  • 2. Obtaining hyperimmune anti-coli (anti-Escherichia) human plasma.
    Skurkovich SV; Likhoded VG; Golubeva IV; Krokhina MA; Demidova NV; Temper RM; Arkhipova NA; Andronova NI; Moshiashvili IJ
    Biomedicine; 1977 Oct; 27(7):258-60. PubMed ID: 338047
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of active and passive antibacterial immunization on skin allograft survival in rabbits.
    Liska M; Hatala M
    Folia Biol (Praha); 1979; 25(1):70-5. PubMed ID: 107050
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Laboratory experiments on the possibilities of oral immunization by means of a sodium desoxycholate extract from dyspepsia coli strains. 8. Serum antibodies the Fragraeus mixed hemadsorption reaction in immunized and challenged mice].
    Ocklitz HW; Mochmann H; Hering L; Schmidt EF; Richter U
    Zentralbl Bakteriol Orig; 1969 Jan; 209(2):161-8. PubMed ID: 4917052
    [No Abstract]   [Full Text] [Related]  

  • 5. [Detection of specific antibodies in anti-Escherichia coli donor plasma and of its isolated immunoglobulins].
    Arkhipov NA; Golodnenkova VN; Krokhina MA; Temner RM; Moshiashvili IIa
    Probl Gematol Pereliv Krovi; 1981 Mar; 26(3):45-7. PubMed ID: 7015315
    [No Abstract]   [Full Text] [Related]  

  • 6. [Oral immunization against colienteritis with streptomycin-dependent E. coli. II. Comparison of the effectivity of vaccines from live streptomycin-dependent and killed EC-0111 B4 bacteria by testing the agglutinin formation in mice and rabbits, the bactericidal activity of rabbit serums and the passive protection trial in mice].
    Koch H; Linde K; Kittlick M; Stelzner A
    Zentralbl Bakteriol Orig; 1969; 211(4):466-75. PubMed ID: 4916987
    [No Abstract]   [Full Text] [Related]  

  • 7. [Production of a hyperimmune antitoxic donor plasma against Pseudomonas aeruginosa].
    Krokhina MA; Davatdarova GM; Cherkas GP; Podgornaia LG; Shinkarenko AA
    Zh Mikrobiol Epidemiol Immunobiol; 1980 Sep; (9):78-83. PubMed ID: 6778040
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Systematic generation of antigen specific human monoclonal antibodies with therapeutical activities using active immunization.
    Lang AB; Fürer E; Senyk G; Larrick JW; Cryz SJ
    Hum Antibodies Hybridomas; 1990; 1(2):96-103. PubMed ID: 2129420
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunity to Escherichia coli in pigs: serologic response to sows given formalin-treated live Escherichia coli vaccine.
    Wilson MR; Svendsen J
    Am J Vet Res; 1971 Jun; 32(6):891-8. PubMed ID: 4933878
    [No Abstract]   [Full Text] [Related]  

  • 10. Active and passive immunity against Pseudomonas aeruginosa with a ribosomal vaccine and antiserum in C3H/HeJ mice.
    Lieberman MM; Ayala E
    J Immunol; 1983 Jul; 131(1):1-3. PubMed ID: 6408166
    [No Abstract]   [Full Text] [Related]  

  • 11. [Preventive properties of hyperimmune coli-sera].
    Kurashvili TK
    Veterinariia; 1978 Aug; (8):47-9. PubMed ID: 358552
    [No Abstract]   [Full Text] [Related]  

  • 12. [Phagocytic activity of mouse peritoneal macrophages under administration of bacterial vaccines and prospidin].
    Pavlenko NV
    Mikrobiol Z; 2002; 64(5):53-8. PubMed ID: 12557494
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunization with R mutants of S. Minnesota. I. Protection against challenge with heterologous gram-negative bacilli.
    McCabe WR
    J Immunol; 1972 Mar; 108(3):601-10. PubMed ID: 4622185
    [No Abstract]   [Full Text] [Related]  

  • 14. Studies on phagocytosis of mucoid and nonmucoid variants of Pseudomonas aeruginosa. I. Induction of homologous immunity by nonmucoid strains of P. aeruginosa.
    Gościniak G; Grzybek-Hryncewicz K
    Arch Immunol Ther Exp (Warsz); 1988; 36(2):177-84. PubMed ID: 2467637
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of polyvalent anti-Pseudomonas aeruginosa vaccine in phagocytic reaction.
    Grzybek-Hryncewicz K; Gościniak G
    Arch Immunol Ther Exp (Warsz); 1990; 38(3-4):291-7. PubMed ID: 2129384
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antitoxic immunity against the so-called lung toxin produced by Escherichia coli.
    Emödy L; Kétyi I; Kuch B; Pácsa S
    Acta Microbiol Acad Sci Hung; 1979; 26(3):233-9. PubMed ID: 396766
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Consequences of active or passive immunization of turkeys against Escherichia coli O78.
    Arp LH
    Avian Dis; 1980; 24(4):808-15. PubMed ID: 7023456
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Experimental infection of immunized mice homologous and heterologous serotypes with Pseudomonas aeruginosa].
    Vidal G; Mynard MC
    Ann Inst Pasteur (Paris); 1972 Jun; 122(6):1129-35. PubMed ID: 4627762
    [No Abstract]   [Full Text] [Related]  

  • 19. Pseudomonas aeruginosa. II. Experimental acellular vaccine of an endotoxin and anatoxin type.
    Bĕlohlávek S; Pavlík V; Rencová J; Stránský V; Nováková L; Sourek J; Výmola F
    J Hyg Epidemiol Microbiol Immunol; 1987; 31(3):343-52. PubMed ID: 3119704
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pseudomonas aeruginosa. Vaccines and immunotherapy.
    Pennington JE
    Infect Dis Clin North Am; 1990 Jun; 4(2):259-70. PubMed ID: 2111838
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.